Dompe to pay $32 million over Medicare co-pay scheme for eye drug
Dompe U.S. Inc., the American subsidiary of Italy-based Dompe farmaceutici S.p.A., has agreed to pay $32 million to resolve allegations that it violated the Anti-Kickback Statute and the False Claims Act, the Justice Department announced.
Original Source
Read the full article at Washingtontimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.